Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

24 structures for P08670

Entry ID Method Resolution Chain Position Source
1GK4 X-ray 230 A A/B/C/D/E/F 328-411 PDB
1GK6 X-ray 190 A A/B 385-412 PDB
1GK7 X-ray 140 A A 102-138 PDB
3G1E X-ray 183 A A/B 102-138 PDB
3KLT X-ray 270 A A/B/C/D 263-334 PDB
3S4R X-ray 245 A A/B 99-189 PDB
3SSU X-ray 260 A A/B 99-189 PDB
3SWK X-ray 170 A A/B 153-238 PDB
3TRT X-ray 230 A A/B 261-335 PDB
3UF1 X-ray 281 A A/B/C/D 144-251 PDB
4MCY X-ray 230 A C 66-78 PDB
4MCZ X-ray 241 A C 59-71 PDB
4MD0 X-ray 219 A C 59-71 PDB
4MD5 X-ray 165 A C 66-78 PDB
4MDI X-ray 200 A C 66-78 PDB
4MDJ X-ray 170 A C 66-78 PDB
4YPC X-ray 144 A A 161-243 PDB
4YV3 X-ray 200 A A/B/C 161-238 PDB
5WHF X-ray 225 A A/B/C/D/E/F/G/H 153-238 PDB
6ATF X-ray 190 A C/F 59-71 PDB
6ATI X-ray 198 A C/F 59-71 PDB
6BIR X-ray 230 A C 419-431 PDB
6YXK X-ray 200 A C 59-74 PDB
AF-P08670-F1 Predicted AlphaFoldDB

407 variants for P08670

Variant ID(s) Position Change Description Diseaes Association Provenance
RCV000203397
rs864309690
RCV000488584
6 V>missing Cataract 30 Developmental cataract [ClinVar] Yes ClinVar
dbSNP
CA5426364
RCV000651306
rs773938980
56 S>Y Cataract 30 [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
CA214748
rs121917775
RCV000056967
RCV000012983
VAR_070100
151 E>K Cataract 30 CTRCT30; the mutation increases the proteasome activity in transfected cells; causes also a severe kinetic defect in vimentin assembly both in vitro and in vivo [ClinVar, UniProt] Yes ClinGen
ClinVar
UniProt
TOPMed
dbSNP
gnomAD
RCV001220959
rs1846752790
156 E>D Cataract 30 [ClinVar] Yes ClinVar
dbSNP
RCV000952394
rs149942621
CA5426418
181 D>A Cataract 30 [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
CA16622109
VAR_078860
RCV000488719
rs1085307141
208 Q>R Cataract 30 CTRCT30; unknown pathological significance [ClinVar, UniProt] Yes ClinGen
ClinVar
UniProt
dbSNP
gnomAD
RCV002547220
rs145152785
CA5426556
250 Q>R Cataract 30 [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
CA5426558
rs773762488
RCV001232814
253 H>R Cataract 30 [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
RCV001195968
CA5426688
rs749084801
381 R>C Cataract 30 [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
rs1846907790
RCV001236540
459 S>missing Cataract 30 [ClinVar] Yes ClinVar
dbSNP
CA5426330
rs756656437
2 S>P No ClinGen
ExAC
rs1436554874
CA376174573
4 R>G No ClinGen
gnomAD
TCGA novel 5 S>A Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA376174615
rs1230052576
6 V>A No ClinGen
gnomAD
CA5426333
rs755242950
6 V>M No ClinGen
ExAC
gnomAD
rs779204525
RCV000994358
CA376174641
8 S>L No ClinGen
ClinVar
ExAC
dbSNP
gnomAD
CA376174631
rs1288770216
8 S>T No ClinGen
gnomAD
CA5426334
rs779204525
8 S>W No ClinGen
ExAC
gnomAD
rs1452327776
CA376174680
11 Y>C No ClinGen
gnomAD
CA376174689
rs1220895620
12 R>C No ClinGen
gnomAD
rs1245254535
CA376174697
12 R>P No ClinGen
gnomAD
rs1220895620
CA376174688
12 R>S No ClinGen
gnomAD
rs1031859925
CA203595558
13 R>S No ClinGen
Ensembl
CA376174726
rs1278642875
14 M>T No ClinGen
gnomAD
TCGA novel 15 F>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs773471865
CA5426338
16 G>R No ClinGen
ExAC
gnomAD
CA5426339
rs747053288
17 G>C No ClinGen
ExAC
gnomAD
rs11545549
CA203595583
18 P>L No ClinGen
gnomAD
rs771023210
CA5426340
19 G>S No ClinGen
ExAC
gnomAD
rs776383614
CA5426341
21 A>E No ClinGen
ExAC
gnomAD
CA5426342
rs776383614
21 A>V No ClinGen
ExAC
gnomAD
rs1202092452
CA376174847
22 S>R No ClinGen
gnomAD
rs527439944
CA203595610
23 R>Q No ClinGen
Ensembl
rs910563895
CA203595603
23 R>W No ClinGen
TOPMed
rs957631225
CA203595614
25 S>R No ClinGen
Ensembl
rs775343323
CA376174900
27 S>G No ClinGen
ExAC
TOPMed
gnomAD
CA376174904
rs1356941925
27 S>N No ClinGen
gnomAD
rs775343323
CA5426344
27 S>R No ClinGen
ExAC
TOPMed
gnomAD
CA376174906
rs1356941925
27 S>T No ClinGen
gnomAD
rs1194887764
CA376174916
28 R>W No ClinGen
TOPMed
CA5426345
rs762644216
31 V>L No ClinGen
ExAC
TOPMed
gnomAD
rs763707422
CA5426346
33 T>A No ClinGen
ExAC
gnomAD
rs1344328729
CA376174988
33 T>M Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA5426348
rs756711607
35 T>A No ClinGen
ExAC
TOPMed
gnomAD
rs766889315
CA5426349
36 R>C No ClinGen
ExAC
TOPMed
gnomAD
rs754236131
CA376175027
36 R>H No ClinGen
ExAC
gnomAD
rs754236131
CA5426350
36 R>P No ClinGen
ExAC
gnomAD
CA5426351
rs755500924
41 G>S No ClinGen
ExAC
gnomAD
rs1382854843
CA376175124
42 S>R No ClinGen
gnomAD
rs748519640
CA5426353
43 A>T No ClinGen
ExAC
gnomAD
rs758730926
CA5426354
43 A>V No ClinGen
ExAC
gnomAD
CA376175145
rs1318337726
44 L>P No ClinGen
TOPMed
rs778098458
CA5426356
45 R>H No ClinGen
ExAC
gnomAD
rs778098458
CA5426355
45 R>P No ClinGen
ExAC
gnomAD
rs1335964173
CA376175186
47 S>N No ClinGen
gnomAD
CA5426359
rs745851443
48 T>I No ClinGen
ExAC
CA5426358
rs201189169
48 T>P No ClinGen
ExAC
gnomAD
rs769749512
CA5426360
49 S>G No ClinGen
ExAC
gnomAD
rs1312761190
CA376175216
49 S>N No ClinGen
gnomAD
CA376175217
rs1367516245
49 S>R No ClinGen
gnomAD
TCGA novel 50 R>C Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs11545553
CA203595678
COSM3790665
50 R>H Variant assessed as Somatic; impact. urinary_tract [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
TOPMed
rs775190116
CA5426361
51 S>I No ClinGen
ExAC
gnomAD
rs1588731496
CA376175251
52 L>I No ClinGen
Ensembl
rs1294995968
CA376175281
54 A>P No ClinGen
TOPMed
CA376175291
rs1337671316
54 A>V No ClinGen
TOPMed
gnomAD
CA5426362
rs762699034
55 S>* No ClinGen
ExAC
gnomAD
CA5426363
rs768322635
56 S>A No ClinGen
ExAC
gnomAD
rs749931833
CA5426367
57 P>L No ClinGen
ExAC
TOPMed
gnomAD
rs767007282
CA5426366
57 P>S No ClinGen
ExAC
gnomAD
rs1215537817
CA376175334
58 G>S No ClinGen
Ensembl
CA376175344
rs1564372278
58 G>V No ClinGen
Ensembl
CA376175360
rs1253533842
60 V>M No ClinGen
Ensembl
CA5426369
rs765742006
61 Y>C No ClinGen
ExAC
gnomAD
rs1474263020
CA376175419
64 R>H No ClinGen
TOPMed
rs1402661582
CA376175440
65 S>F No ClinGen
gnomAD
CA376175461
rs1445952624
67 A>D No ClinGen
TOPMed
rs369470034
CA5426371
67 A>T No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA5426372
rs778153530
68 V>M No ClinGen
ExAC
TOPMed
gnomAD
rs928603903
CA203595706
69 R>H No ClinGen
TOPMed
gnomAD
CA376175490
rs928603903
69 R>L No ClinGen
TOPMed
gnomAD
CA376175492
rs928603903
69 R>P No ClinGen
TOPMed
gnomAD
CA376175482
rs1435968814
69 R>S No ClinGen
gnomAD
CA203595711
rs777756098
71 R>Q No ClinGen
TOPMed
gnomAD
CA376175505
rs1235698818
71 R>W Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs1202137863
CA376175525
72 S>N No ClinGen
gnomAD
rs1270633135
CA376175550
74 V>M No ClinGen
gnomAD
CA376175571
rs1402686254
75 P>L No ClinGen
TOPMed
gnomAD
rs757539736
CA5426375
75 P>S No ClinGen
ExAC
gnomAD
CA5426376
rs781179445
76 G>E No ClinGen
ExAC
gnomAD
rs972743635
CA203595723
76 G>R No ClinGen
gnomAD
rs11545548
CA203595757
77 V>A No ClinGen
ExAC
gnomAD
CA5426378
rs11545548
77 V>G No ClinGen
ExAC
gnomAD
rs184701100
CA376175588
77 V>L No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA5426377
rs184701100
77 V>M No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA376175602
rs1325594598
78 R>Q No ClinGen
gnomAD
rs865981174
CA203595765
78 R>W No ClinGen
gnomAD
rs867740022
CA203595767
81 Q>* No ClinGen
Ensembl
CA376175651
rs1413835853
82 D>N No ClinGen
gnomAD
CA203595769
rs1050023359
84 V>L No ClinGen
gnomAD
CA376175707
rs1385094399
85 D>E No ClinGen
TOPMed
CA5426380
rs749097460
85 D>N No ClinGen
ExAC
gnomAD
rs1324531976
CA376175712
86 F>L No ClinGen
gnomAD
rs1221861802
CA376175750
88 L>P No ClinGen
gnomAD
rs1330720517
CA376175740
88 L>V No ClinGen
gnomAD
rs1290632621
CA376175762
89 A>V No ClinGen
gnomAD
CA376175788
rs1228337366
91 A>T No ClinGen
gnomAD
CA376175821
rs1259476721
93 N>T No ClinGen
gnomAD
rs1452623960
CA376175833
94 T>A No ClinGen
TOPMed
CA203595779
rs868327359
95 E>* No ClinGen
Ensembl
CA376175849
rs1267669767
95 E>A No ClinGen
gnomAD
CA5426382
rs774132663
96 F>L No ClinGen
ExAC
TOPMed
gnomAD
CA376175897
rs529112487
98 N>D No ClinGen
1000Genomes
gnomAD
CA376175903
rs1253712799
98 N>S No ClinGen
gnomAD
rs529112487
CA203595786
98 N>Y No ClinGen
1000Genomes
gnomAD
CA376176010
rs1361987967
106 E>* No ClinGen
gnomAD
CA376176014
rs1459555504
106 E>V No ClinGen
gnomAD
CA203595787
rs867113544
107 L>M No ClinGen
Ensembl
CA376176024
rs1390058731
108 Q>* No ClinGen
gnomAD
CA376176026
rs1403341247
108 Q>R No ClinGen
gnomAD
rs534064028
CA376176056
112 D>E No ClinGen
gnomAD
CA5426384
rs546992824
112 D>N No ClinGen
1000Genomes
ExAC
gnomAD
CA376176052
rs546992824
112 D>Y No ClinGen
1000Genomes
ExAC
gnomAD
CA376176060
rs1305547785
113 R>C No ClinGen
gnomAD
rs1246101455
CA376176066
114 F>L No ClinGen
gnomAD
rs943771920
CA203595793
116 N>K No ClinGen
Ensembl
rs772634201
CA5426385
117 Y>H No ClinGen
ExAC
gnomAD
rs1425939424
CA376176147
125 E>D No ClinGen
TOPMed
CA203595794
rs565243670
126 Q>R No ClinGen
Ensembl
TCGA novel 127 Q>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA376176155
rs1483298145
127 Q>K No ClinGen
gnomAD
CA5426386
rs760190137
127 Q>R No ClinGen
ExAC
gnomAD
CA376176182
rs902288870
130 I>N No ClinGen
TOPMed
gnomAD
CA203595798
rs902288870
130 I>T No ClinGen
TOPMed
gnomAD
CA203595814
rs1053391219
131 L>P No ClinGen
Ensembl
rs1216233618
CA376176188
132 L>M No ClinGen
gnomAD
CA376176205
rs1045526760
134 E>D No ClinGen
TOPMed
gnomAD
rs532905834
CA5426391
135 L>F No ClinGen
1000Genomes
ExAC
gnomAD
rs1437046531
CA376176232
138 L>P No ClinGen
TOPMed
rs1296829264
CA376176256
142 G>S No ClinGen
TOPMed
gnomAD
CA5426392
rs757461918
144 S>W No ClinGen
ExAC
TOPMed
gnomAD
CA5426393
rs781436766
145 R>C No ClinGen
ExAC
gnomAD
TCGA novel 146 L>M Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1243129674
CA376176296
148 D>E No ClinGen
TOPMed
gnomAD
rs750493891
CA5426394
148 D>N Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs1245849739
CA376176299
149 L>F Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
rs1281806487
CA376176317
151 E>D No ClinGen
TOPMed
rs141319821
CA5426395
152 E>K No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA203595843
rs999034093
153 E>A No ClinGen
TOPMed
rs779864520
CA5426396
154 M>I No ClinGen
ExAC
gnomAD
CA376176337
rs1323790047
154 M>T No ClinGen
TOPMed
rs778724394
CA5426399
155 R>Q No ClinGen
ExAC
gnomAD
CA5426397
rs749293841
155 R>W No ClinGen
ExAC
gnomAD
CA5426400
rs747904058
156 E>K Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA376176352
rs1406458665
157 L>V No ClinGen
TOPMed
rs1457202484
CA376176358
158 R>C No ClinGen
Ensembl
CA376176359
rs1442903146
158 R>H No ClinGen
gnomAD
rs771651752
CA5426401
159 R>Q No ClinGen
ExAC
TOPMed
gnomAD
CA5426403
rs746513281
161 V>G No ClinGen
ExAC
gnomAD
rs772870142
CA5426402
161 V>M No ClinGen
ExAC
gnomAD
rs201551781
CA5426405
163 Q>H No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs377524590
CA5426406
164 L>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA5426407
rs569704234
165 T>S No ClinGen
1000Genomes
ExAC
gnomAD
rs774888281
CA5426408
166 N>K No ClinGen
ExAC
gnomAD
CA5426409
rs762190767
167 D>G No ClinGen
ExAC
CA376176409
rs267602430
167 D>H No ClinGen
Ensembl
rs267602430
CA203595863
167 D>N No ClinGen
Ensembl
CA5426410
rs767649276
169 A>G No ClinGen
ExAC
gnomAD
TCGA novel 170 R>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1361960709
CA376176428
170 R>S No ClinGen
gnomAD
rs11545550
CA203595882
172 E>Q No ClinGen
Ensembl
CA5426413
rs766499205
173 V>A No ClinGen
ExAC
TOPMed
gnomAD
CA5426412
rs756282194
173 V>M No ClinGen
ExAC
TOPMed
gnomAD
CA203595888
rs746924511
174 E>D No ClinGen
TOPMed
gnomAD
TCGA novel 175 R>C Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 175 R>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1313812412
CA376176458
175 R>S No ClinGen
gnomAD
rs1459941371
CA376176479
177 N>K No ClinGen
gnomAD
rs1262487660
CA376176478
177 N>S No ClinGen
gnomAD
rs1200409133
CA376176486
179 A>T No ClinGen
TOPMed
rs866834871
CA203595901
180 E>K No ClinGen
TOPMed
gnomAD
rs1035750972
CA203595913
182 I>S No ClinGen
Ensembl
CA376176507
rs1434157425
182 I>V No ClinGen
gnomAD
CA376176516
rs1427593011
183 M>K No ClinGen
TOPMed
gnomAD
rs972689698
CA203595932
183 M>L No ClinGen
gnomAD
CA376176513
rs972689698
183 M>V No ClinGen
gnomAD
rs1459289381
CA376176522
184 R>C No ClinGen
TOPMed
gnomAD
CA376176523
rs1321743889
184 R>H No ClinGen
gnomAD
CA376176520
rs1459289381
184 R>S No ClinGen
TOPMed
gnomAD
rs11545551
CA203595935
185 L>P No ClinGen
Ensembl
rs201325757
CA5426419
185 L>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA376176532
rs1588732106
186 R>Q No ClinGen
Ensembl
rs777297315
COSM1560852
CA5426420
187 E>K large_intestine [Cosmic] No ClinGen
cosmic curated
ExAC
gnomAD
rs1343201036
CA376176546
188 K>R No ClinGen
TOPMed
CA5426474
rs373295180
191 E>K No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA376177044
rs1334832994
192 E>V No ClinGen
gnomAD
rs767474660
CA5426475
193 M>I No ClinGen
ExAC
gnomAD
rs1007423361
CA203596469
193 M>L No ClinGen
Ensembl
rs1005304137
CA203596474
193 M>T No ClinGen
TOPMed
rs1228442247
CA376177077
194 L>R No ClinGen
gnomAD
CA376177083
rs1303380482
195 Q>* No ClinGen
TOPMed
rs1406182336
CA376177121
198 E>K No ClinGen
TOPMed
CA376177134
rs1363228886
199 A>T No ClinGen
TOPMed
CA5426476
rs145760831
200 E>G No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1037734535
CA203596490
200 E>Q No ClinGen
TOPMed
gnomAD
CA376177167
rs765911800
201 N>I No ClinGen
ExAC
gnomAD
CA5426478
rs765911800
201 N>S No ClinGen
ExAC
gnomAD
CA376177165
rs1461281372
201 N>Y No ClinGen
gnomAD
rs866251474
CA203596498
202 T>I No ClinGen
Ensembl
CA376177188
rs1386842396
203 L>V No ClinGen
TOPMed
CA376177211
rs143636314
204 Q>H No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA376178189
rs1448514100
209 D>N No ClinGen
TOPMed
gnomAD
rs1455890040
CA376178217
211 D>N No ClinGen
TOPMed
CA5426516
rs760525619
212 N>D No ClinGen
ExAC
gnomAD
CA5426517
rs116800063
212 N>S No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA5426518
rs776474793
213 A>V No ClinGen
ExAC
gnomAD
rs138235394
CA5426520
216 A>T No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs752236825
COSM916835
CA5426521
217 R>C Variant assessed as Somatic; 0.0 impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
TOPMed
gnomAD
rs762391438
CA5426522
217 R>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA376178296
rs752236825
217 R>S No ClinGen
ExAC
TOPMed
gnomAD
CA376178318
rs1349809735
219 D>H No ClinGen
TOPMed
rs1304135302
CA376178365
222 R>C No ClinGen
TOPMed
CA5426524
rs750994048
222 R>H No ClinGen
ExAC
gnomAD
CA203597800
rs897144372
225 E>K No ClinGen
TOPMed
gnomAD
CA376178443
rs1301514675
226 S>C No ClinGen
TOPMed
CA376178457
rs1305482290
227 L>F No ClinGen
TOPMed
gnomAD
CA5426525
rs756629184
228 Q>R No ClinGen
ExAC
gnomAD
CA5426526
rs780328725
229 E>D No ClinGen
ExAC
gnomAD
CA5426527
rs754196814
230 E>D No ClinGen
ExAC
TOPMed
gnomAD
rs1358309285
CA376178510
231 I>T No ClinGen
gnomAD
CA5426528
rs755181628
237 L>P No ClinGen
ExAC
gnomAD
CA376178637
rs1248288717
239 E>D No ClinGen
gnomAD
COSM538117
CA5426530
rs748255267
239 E>K lung Variant assessed as Somatic; 0.0 impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
ExAC
NCI-TCGA
gnomAD
CA376178644
rs1399047851
240 E>* No ClinGen
TOPMed
rs550798765
CA5426531
240 E>V No ClinGen
1000Genomes
ExAC
gnomAD
CA203597865
rs992484456
243 Q>R No ClinGen
TOPMed
TCGA novel 247 A>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1445166789
CA376178839
249 I>F No ClinGen
gnomAD
rs1290316532
CA376178853
250 Q>E No ClinGen
gnomAD
rs776147609
CA5426557
252 Q>R No ClinGen
ExAC
gnomAD
rs761334638
CA5426560
253 H>Q No ClinGen
ExAC
TOPMed
gnomAD
CA5426562
rs139037306
256 I>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA5426564
rs753092108
COSM916836
257 D>N Variant assessed as Somatic; 0.0 impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
gnomAD
CA5426565
rs758735029
258 V>M No ClinGen
ExAC
gnomAD
rs985623715
CA203597884
260 V>I No ClinGen
TOPMed
gnomAD
rs1257540470
CA376179020
261 S>A No ClinGen
TOPMed
CA376179032
rs1480960201
261 S>F No ClinGen
gnomAD
CA203597885
rs113576905
266 T>A No ClinGen
TOPMed
CA376179104
rs150878383
266 T>K No ClinGen
ESP
ExAC
TOPMed
gnomAD
COSM916837
CA5426567
rs150878383
266 T>M Variant assessed as Somatic; 0.0 impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
CA376179101
rs113576905
266 T>S No ClinGen
TOPMed
CA376179123
rs1402903305
267 A>V No ClinGen
gnomAD
rs781127817
CA5426569
269 L>P No ClinGen
ExAC
gnomAD
rs1452626097
CA376179158
270 R>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
rs199515026
CA5426573
272 V>I No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA376179198
rs1175193193
273 R>C No ClinGen
Ensembl
CA5426574
rs371176373
273 R>H No ClinGen
ESP
ExAC
TOPMed
gnomAD
TCGA novel 273 R>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA376179264
rs1232637574
277 E>G No ClinGen
TOPMed
gnomAD
CA5426576
rs747619298
277 E>K No ClinGen
ExAC
gnomAD
rs1048526047
CA203597914
278 S>N No ClinGen
TOPMed
gnomAD
CA376179294
rs1285046692
279 V>A No ClinGen
gnomAD
rs1356703491
CA376179291
279 V>L No ClinGen
TOPMed
rs147133187
CA5426577
280 A>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs772585290
CA5426578
281 A>V No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 288 E>D Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs776031097
CA5426581
288 E>K No ClinGen
ExAC
gnomAD
rs1471445445
CA376179432
289 E>* No ClinGen
gnomAD
rs763360647
CA5426582
291 Y>H No ClinGen
ExAC
rs764236805
CA5426583
293 S>Y No ClinGen
ExAC
CA5426606
rs747735685
295 F>S Variant assessed as Somatic; 9.301e-05 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA376179827
rs578255169
296 A>S No ClinGen
gnomAD
CA203598408
rs578255169
296 A>T No ClinGen
gnomAD
TCGA novel 297 D>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA376179856
rs1327165886
300 E>D No ClinGen
TOPMed
rs144238562
CA5426607
300 E>G No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs754861364
CA5426608
301 A>S No ClinGen
ExAC
gnomAD
TCGA novel 301 A>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA5426609
rs778821394
302 A>S No ClinGen
ExAC
gnomAD
rs752407631
CA5426610
303 N>S No ClinGen
ExAC
TOPMed
gnomAD
rs752407631
CA376179872
303 N>T No ClinGen
ExAC
TOPMed
gnomAD
rs552165238
CA5426612
304 R>Q No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs758102529
CA5426611
304 R>W No ClinGen
ExAC
TOPMed
gnomAD
CA5426613
rs746534016
306 N>S No ClinGen
ExAC
TOPMed
gnomAD
rs1393644707
CA376179897
307 D>G No ClinGen
gnomAD
rs11545546
CA203598446
308 A>S No ClinGen
gnomAD
CA376179902
rs11545546
308 A>T No ClinGen
gnomAD
CA376179907
rs1328451159
309 L>V No ClinGen
gnomAD
rs780835078
CA5426615
310 R>H No ClinGen
ExAC
gnomAD
CA5426616
rs749857760
311 Q>R No ClinGen
ExAC
gnomAD
rs1316382347
CA376179933
313 K>R No ClinGen
gnomAD
TCGA novel 314 Q>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA5426617
rs769012996
315 E>K No ClinGen
ExAC
TOPMed
gnomAD
rs1588735455
CA376179961
317 T>N No ClinGen
Ensembl
rs1264296526
CA376179967
318 E>A No ClinGen
gnomAD
CA5426618
COSM1321432
rs371431143
320 R>Q ovary Variant assessed as Somatic; 0.0 impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
ESP
ExAC
NCI-TCGA
gnomAD
CA376180005
rs1171701809
324 Q>E No ClinGen
TOPMed
rs772347590
CA5426620
324 Q>H No ClinGen
ExAC
TOPMed
gnomAD
rs779403092
CA203598462
324 Q>R No ClinGen
Ensembl
CA5426621
rs773352810
325 S>C No ClinGen
ExAC
gnomAD
rs1374235575
CA376180026
327 T>S No ClinGen
TOPMed
rs760880333
CA5426622
328 C>Y No ClinGen
ExAC
gnomAD
rs1588735491
CA376180053
331 D>V No ClinGen
Ensembl
rs200772352
CA203598493
332 A>T No ClinGen
ESP
TOPMed
gnomAD
rs753894774
CA5426624
333 L>F No ClinGen
ExAC
gnomAD
rs924667179
CA203598498
335 G>E No ClinGen
Ensembl
rs111932484 336 T>= Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No NCI-TCGA
CA5426656
rs778153870
337 N>S No ClinGen
ExAC
TOPMed
gnomAD
rs369763215
CA203598664
337 N>Y No ClinGen
Ensembl
CA5426657
rs747338188
341 E>K No ClinGen
ExAC
gnomAD
CA5426658
rs771168882
342 R>C No ClinGen
ExAC
TOPMed
gnomAD
CA5426659
rs376802470
342 R>H No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA5426661
rs769833820
344 M>I No ClinGen
ExAC
gnomAD
COSM258350
CA5426662
rs775627643
345 R>C Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
TOPMed
gnomAD
CA376180388
rs775627643
345 R>G No ClinGen
ExAC
TOPMed
gnomAD
CA5426663
rs116370722
345 R>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
1000Genomes
ExAC
NCI-TCGA
gnomAD
TCGA novel 346 E>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1049424533
CA203598685
347 M>I No ClinGen
TOPMed
CA5426665
rs200740172
351 F>V No ClinGen
ExAC
TOPMed
gnomAD
rs866598895
CA203598702
352 A>V Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
Ensembl
NCI-TCGA
rs767278443
CA5426667
353 V>I No ClinGen
ExAC
gnomAD
CA203598716
rs766141377
354 E>A No ClinGen
gnomAD
rs766141377
CA376180536
354 E>G No ClinGen
gnomAD
rs750107979
CA5426668
355 A>V No ClinGen
ExAC
gnomAD
CA376180609
rs1197860827
359 Q>K No ClinGen
gnomAD
CA376180613
rs1261710176
359 Q>R No ClinGen
TOPMed
rs139818786
CA5426669
360 D>E No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA5426670
rs765859276
361 T>A No ClinGen
ExAC
gnomAD
rs114322672
CA5426671
362 I>N No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs114322672
CA5426672
362 I>T No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA5426673
rs778207118
363 G>D No ClinGen
ExAC
gnomAD
rs751935909
CA5426674
364 R>C No ClinGen
ExAC
TOPMed
gnomAD
CA203598729
rs371054027
364 R>H No ClinGen
ESP
CA5426676
rs781618375
368 E>D No ClinGen
ExAC
TOPMed
gnomAD
rs746135750
CA5426677
372 M>R No ClinGen
ExAC
TOPMed
gnomAD
rs746135750
CA376180802
372 M>T No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 372 M>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA5426678
rs770025384
373 K>R No ClinGen
ExAC
TOPMed
gnomAD
rs768727457
CA5426681
375 E>K No ClinGen
ExAC
gnomAD
rs761834421
CA5426685
378 R>H No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 378 R>missing Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA5426683
rs201530534
378 R>C No ClinGen
1000Genomes
ExAC
TOPMed
rs761834421
CA5426684
378 R>P No ClinGen
ExAC
TOPMed
gnomAD
rs760289106
CA5426687
379 H>P No ClinGen
ExAC
gnomAD
CA376180920
rs1358822322
380 L>I Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
CA376180929
rs1218008674
380 L>P No ClinGen
gnomAD
CA5426689
rs35157876
381 R>H No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA376180943
rs35157876
381 R>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA376180967
rs1188442437
383 Y>H No ClinGen
gnomAD
rs1267792443
CA376180983
384 Q>* No ClinGen
gnomAD
CA5426692
rs752126893
386 L>V No ClinGen
ExAC
gnomAD
CA376181038
rs1588736025
RCV000853405
387 L>P No ClinGen
ClinVar
Ensembl
dbSNP
CA376181091
rs1432057333
391 M>V No ClinGen
gnomAD
CA376181141
rs1258626020
394 D>V No ClinGen
TOPMed
CA376181162
rs1176198427
395 I>M No ClinGen
gnomAD
CA376181156
rs1470562734
395 I>T No ClinGen
gnomAD
rs1357615634
CA376181193
397 I>T No ClinGen
gnomAD
TCGA novel 406 G>A Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 407 E>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1564374858
RCV000732045
CA376181342
408 E>K No ClinGen
ClinVar
Ensembl
dbSNP
rs750758121
CA5426695
409 S>R No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 410 R>= Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA5426714
rs373859810
410 R>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs750766626
CA5426715
412 S>Y No ClinGen
ExAC
gnomAD
rs756434736
CA5426716
415 L>F No ClinGen
ExAC
gnomAD
rs1564374995
CA376181531
416 P>A No ClinGen
Ensembl
CA203599064
rs11545541
416 P>Q No ClinGen
Ensembl
rs1276819494
CA376181544
417 N>D No ClinGen
TOPMed
rs1490612095
CA376181595
420 S>F Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs1038093456
CA203599085
421 L>P Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
CA5426718
rs754167157
422 N>S No ClinGen
ExAC
TOPMed
gnomAD
rs760767925
CA203599100
423 L>M No ClinGen
Ensembl
CA203599390
rs955350530
430 S>A No ClinGen
TOPMed
CA376181844
rs982699474
431 L>I No ClinGen
TOPMed
CA203599392
rs982699474
431 L>V No ClinGen
TOPMed
CA376181855
rs768266467
433 L>V No ClinGen
ExAC
gnomAD
CA376181860
rs146586974
434 V>F No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA5426750
rs146586974
434 V>I No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA376181874
rs1467601802
436 T>A No ClinGen
TOPMed
CA376181888
rs1442649286
438 S>P No ClinGen
gnomAD
rs1371902872
CA376181894
439 K>E No ClinGen
TOPMed
CA5426752
rs372394023
439 K>R No ClinGen
ESP
ExAC
gnomAD
rs777161019
CA5426753
442 L>P No ClinGen
ExAC
gnomAD
CA376181919
rs1424831707
443 L>V No ClinGen
TOPMed
CA5426756
rs753033876
444 I>M No ClinGen
ExAC
gnomAD
CA5426755
rs765564921
444 I>N No ClinGen
ExAC
gnomAD
CA5426757
rs763073277
446 T>M No ClinGen
ExAC
gnomAD
rs1460602699
CA376181975
451 D>E No ClinGen
TOPMed
CA5426760
rs757220075
452 G>E No ClinGen
ExAC
gnomAD
rs1414174359
CA376181982
453 Q>* No ClinGen
gnomAD
rs1414174359
CA376181983
453 Q>E No ClinGen
gnomAD
rs1214438836
CA376182003
454 V>I No ClinGen
TOPMed
CA5426787
rs779935723
456 N>D No ClinGen
ExAC
TOPMed
gnomAD
rs754678758
CA5426789
457 E>G No ClinGen
ExAC
TOPMed
gnomAD
CA203599907
rs376668602
457 E>K No ClinGen
ESP
gnomAD
CA5426791
rs747701399
458 T>A No ClinGen
ExAC
TOPMed
gnomAD
CA376182030
rs771777895
458 T>I No ClinGen
ExAC
gnomAD
CA5426792
rs771777895
458 T>N No ClinGen
ExAC
gnomAD
TCGA novel 460 Q>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 460 Q>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA5426793
rs777412987
461 H>P No ClinGen
ExAC
gnomAD
CA376182053
rs1158260463
462 H>D No ClinGen
gnomAD
rs11545543
CA203599925
462 H>P No ClinGen
Ensembl
rs775956508
CA5426796
463 D>G No ClinGen
ExAC
gnomAD
CA5426795
rs372258946
463 D>N Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
rs781197884
CA203599960
464 D>E No ClinGen
TOPMed
gnomAD
CA5426797
rs763181437
464 D>H No ClinGen
ExAC
gnomAD

No associated diseases with P08670

1 regional properties for P08670

Type Name Position InterPro Accession
domain AP2/ERF domain 53 - 117 IPR001471

Functions

Description
EC Number
Subcellular Localization
  • Cytoplasm
  • Cytoplasm, cytoskeleton
  • Nucleus matrix
  • Cell membrane
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

16 GO annotations of cellular component

Name Definition
axon The long process of a neuron that conducts nerve impulses, usually away from the cell body to the terminals and varicosities, which are sites of storage and release of neurotransmitter.
cell leading edge The area of a motile cell closest to the direction of movement.
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
cytoskeleton A cellular structure that forms the internal framework of eukaryotic and prokaryotic cells. The cytoskeleton includes intermediate filaments, microfilaments, microtubules, the microtrabecular lattice, and other structures characterized by a polymeric filamentous nature and long-range order within the cell. The various elements of the cytoskeleton not only serve in the maintenance of cellular shape but also have roles in other cellular functions, including cellular movement, cell division, endocytosis, and movement of organelles.
cytosol The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
extracellular exosome A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
focal adhesion A cell-substrate junction that anchors the cell to the extracellular matrix and that forms a point of termination of actin filaments. In insects focal adhesion has also been referred to as hemi-adherens junction (HAJ).
intermediate filament A cytoskeletal structure that forms a distinct elongated structure, characteristically 10 nm in diameter, that occurs in the cytoplasm of eukaryotic cells. Intermediate filaments form a fibrous system, composed of chemically heterogeneous subunits and involved in mechanically integrating the various components of the cytoplasmic space. Intermediate filaments may be divided into five chemically distinct classes: Type I, acidic keratins; Type II, basic keratins; Type III, including desmin, vimentin and others; Type IV, neurofilaments and related filaments; and Type V, lamins.
intermediate filament cytoskeleton Cytoskeletal structure made from intermediate filaments, typically organized in the cytosol as an extended system that stretches from the nuclear envelope to the plasma membrane. Some intermediate filaments run parallel to the cell surface, while others traverse the cytosol; together they form an internal framework that helps support the shape and resilience of the cell.
microtubule organizing center An intracellular structure that can catalyze gamma-tubulin-dependent microtubule nucleation and that can anchor microtubules by interacting with their minus ends, plus ends or sides.
nuclear matrix The dense fibrillar network lying on the inner side of the nuclear membrane.
peroxisome A small organelle enclosed by a single membrane, and found in most eukaryotic cells. Contains peroxidases and other enzymes involved in a variety of metabolic processes including free radical detoxification, lipid catabolism and biosynthesis, and hydrogen peroxide metabolism.
phagocytic vesicle A membrane-bounded intracellular vesicle that arises from the ingestion of particulate material by phagocytosis.
plasma membrane The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
polysome A multiribosomal structure representing a linear array of ribosomes held together by messenger RNA. They represent the active complexes in cellular protein synthesis and are able to incorporate amino acids into polypeptides both in vivo and in vitro.
ribonucleoprotein complex A macromolecular complex that contains both RNA and protein molecules.

8 GO annotations of molecular function

Name Definition
double-stranded RNA binding Binding to double-stranded RNA.
identical protein binding Binding to an identical protein or proteins.
keratin filament binding Binding to a keratin filament, an intermediate filament composed of acidic and basic keratins (types I and II), typically expressed in epithelial cells.
molecular adaptor activity The binding activity of a molecule that brings together two or more molecules through a selective, non-covalent, often stoichiometric interaction, permitting those molecules to function in a coordinated way.
protein domain specific binding Binding to a specific domain of a protein.
scaffold protein binding Binding to a scaffold protein. Scaffold proteins are crucial regulators of many key signaling pathways. Although not strictly defined in function, they are known to interact and/or bind with multiple members of a signaling pathway, tethering them into complexes.
structural constituent of cytoskeleton The action of a molecule that contributes to the structural integrity of a cytoskeletal structure.
structural constituent of eye lens The action of a molecule that contributes to the structural integrity of the lens of an eye.

13 GO annotations of biological process

Name Definition
astrocyte development The process aimed at the progression of an astrocyte over time, from initial commitment of the cell to a specific fate, to the fully functional differentiated cell. An astrocyte is the most abundant type of glial cell. Astrocytes provide support for neurons and regulate the environment in which they function.
Bergmann glial cell differentiation The process in which neuroepithelial cells of the neural tube give rise to Brgmann glial cells, specialized bipotential progenitors cells of the cerebellum. Differentiation includes the processes involved in commitment of a cell to a specific fate.
cellular response to interferon-gamma Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interferon-gamma stimulus. Interferon gamma is the only member of the type II interferon found so far.
cellular response to lipopolysaccharide Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria.
cellular response to muramyl dipeptide Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a muramyl dipeptide stimulus. Muramyl dipeptide is derived from peptidoglycan.
intermediate filament organization Control of the spatial distribution of intermediate filaments; includes organizing filaments into meshworks, bundles, or other structures, as by cross-linking.
lens fiber cell development The process whose specific outcome is the progression of a lens fiber cell over time, from its formation to the mature structure. Cell development does not include the steps involved in committing a cell to a lens fiber cell fate. A lens fiber cell is any of the elongated, tightly packed cells that make up the bulk of the mature lens in a camera-type eye.
negative regulation of neuron projection development Any process that decreases the rate, frequency or extent of neuron projection development. Neuron projection development is the process whose specific outcome is the progression of a neuron projection over time, from its formation to the mature structure. A neuron projection is any process extending from a neural cell, such as axons or dendrites (collectively called neurites).
neuron projection development The process whose specific outcome is the progression of a neuron projection over time, from its formation to the mature structure. A neuron projection is any process extending from a neural cell, such as axons or dendrites (collectively called neurites).
positive regulation of collagen biosynthetic process Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of collagen, any of a group of fibrous proteins of very high tensile strength that form the main component of connective tissue in animals.
positive regulation of translation Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of proteins by the translation of mRNA or circRNA.
regulation of mRNA stability Any process that modulates the propensity of mRNA molecules to degradation. Includes processes that both stabilize and destabilize mRNAs.
SMAD protein signal transduction The cascade of processes by which a signal interacts with a receptor, causing a change in the activity of a SMAD protein, and ultimately effecting a change in the functioning of the cell.

13 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
P02545 LMNA Prelamin-A/C Homo sapiens (Human) PR
P17661 DES Desmin Homo sapiens (Human) PR
P41219 PRPH Peripherin Homo sapiens (Human) PR
P14136 GFAP Glial fibrillary acidic protein Homo sapiens (Human) PR
P14733 Lmnb1 Lamin-B1 Mus musculus (Mouse) PR
P48678 Lmna Prelamin-A/C Mus musculus (Mouse) PR
P21619 Lmnb2 Lamin-B2 Mus musculus (Mouse) PR
P31001 Des Desmin Mus musculus (Mouse) PR
P20152 Vim Vimentin Mus musculus (Mouse) PR
P03995 Gfap Glial fibrillary acidic protein Mus musculus (Mouse) PR
P70615 Lmnb1 Lamin-B1 Rattus norvegicus (Rat) PR
P48679 Lmna Prelamin-A/C Rattus norvegicus (Rat) PR
Q21065 ifa-3 Intermediate filament protein ifa-3 Caenorhabditis elegans PR
10 20 30 40 50 60
MSTRSVSSSS YRRMFGGPGT ASRPSSSRSY VTTSTRTYSL GSALRPSTSR SLYASSPGGV
70 80 90 100 110 120
YATRSSAVRL RSSVPGVRLL QDSVDFSLAD AINTEFKNTR TNEKVELQEL NDRFANYIDK
130 140 150 160 170 180
VRFLEQQNKI LLAELEQLKG QGKSRLGDLY EEEMRELRRQ VDQLTNDKAR VEVERDNLAE
190 200 210 220 230 240
DIMRLREKLQ EEMLQREEAE NTLQSFRQDV DNASLARLDL ERKVESLQEE IAFLKKLHEE
250 260 270 280 290 300
EIQELQAQIQ EQHVQIDVDV SKPDLTAALR DVRQQYESVA AKNLQEAEEW YKSKFADLSE
310 320 330 340 350 360
AANRNNDALR QAKQESTEYR RQVQSLTCEV DALKGTNESL ERQMREMEEN FAVEAANYQD
370 380 390 400 410 420
TIGRLQDEIQ NMKEEMARHL REYQDLLNVK MALDIEIATY RKLLEGEESR ISLPLPNFSS
430 440 450 460
LNLRETNLDS LPLVDTHSKR TLLIKTVETR DGQVINETSQ HHDDLE